would be interested to hear the insto/brokers thoughts on small caps & biotech's expectations in 2024 now the Fed has overnight flagged interest rate cuts next year.
Maybe the Feds comments are a signal of a turnaround in those sectors?
Ann: Bisantrene Phase 2 AML data presented at ASH conference, page-47
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
-0.100(6.90%) |
Mkt cap ! $236.9M | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.45 | $1.33 | $120.5K | 88.42K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 372 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.35 | 854 | 1 |
View Market Depth
| Last trade - 12.24pm 19/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |